Stability and removal of spironolactone from wastewater

References

• Castiglioni, S.; Bagnati, R.; Fanelli, R.; Pomati, F.; Calamari, D.; Zuccato, E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40, 357–363.
   PubMed Web of Science ®Google Scholar
• Carballa, M.; Omil, F.; Lema, J.M.; Llompart, M.; Garcia-Jares, C.; Rodriguez, I.; Gomez, M.; Ternes, T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 2004, 38, 2918–2926.
   PubMed Web of Science ®Google Scholar
• Ternes, T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32, 3245–3260.
   Web of Science ®Google Scholar
• Radjenovic, J.; Petrovic, M.; Barcelo, D. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal. Bioanal. Chem. 2007, 387, 1365–1377.
   PubMed Web of Science ®Google Scholar
• Lindqvist, N.; Tuhkanen, T.; Kronberg, L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 2005, 39, 2219–2228.
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency (USEPA).Wastewater Treatment Manuals: Primary, Secondary and Tertiary treatment; USEPA: Washington, DC, 1997.
   Google Scholar
• Laurian, V.; Silvia, I.; Dana, M.; Marcela, A.; Daniela-Lucia, M.Determination of spironolactone and canrenone in human plasma byhigh-performance liquid chromatography with mass spectrometry detection.Croat. Chem. Acta 2011, 84(3), 361–366.
   Web of Science ®Google Scholar
• Doggrell, S.A.; Brown, L. The spironolactone renaissance. Expert. Opin. Investig. Drugs 2001, 10, 243–254.
   Google Scholar
• Lloyd, S.J.; Mauro, V.F. Spironolactone in the treatment of congestive heart failure. Ann Pharmacother. 2000, 34, 1336–1340.
   PubMed Web of Science ®Google Scholar
• Noerr, B. Spironolactone. Neonatal Netw. 1999, 18, 43–46.
   PubMedGoogle Scholar
• Gupta, V.D.; Gibbs, C.W.; Ghanekar, A.G. Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone. Am. J. Hosp. Pharm. 1978, 35, 1382–1385.
   PubMedGoogle Scholar
• Mathur, L.K.; Wickman, A. Stability of extemporaneously compounded spironolactone suspensions. Am. J. Hosp. Pharm. 1989, 46, 2040–2042.
   PubMedGoogle Scholar
• Pramar, Y.; Gupta, V.D.; Bethea, C. Development of a stable oral liquid dosage form of spironolactone. J. Clin. Pharm. Ther. 1992, 17, 245–248.
   PubMed Web of Science ®Google Scholar
• Nahata, M.C.; Morosco, R.S.; Hipple, T.F. Stability of spironolactone in an extemporaneously prepared suspension at two temperatures. Ann. Pharmacother. 1993, 27, 1198–1199.
   PubMed Web of Science ®Google Scholar
• Allen, Jr. L.V.; Ericson, M.A. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and Spironolactone in extemporaneously compounded oral liquids. Am. J. Health-Syst. Pharm. 1996, 53, 2073–2078.
   PubMed Web of Science ®Google Scholar
• Allen, Jr, L.V.; Ericson, M.A. Stability of labetalol hydrochloride, metoprololtartarate, verapamil hydrochloride, and spironolactone with hydrochlorotiazide in extemporaneously compounded oral liquids. Am. J. Health-Syst. Pharm. 1996, 53, 2304–2309.
   PubMed Web of Science ®Google Scholar
• Allen, Jr. L.V. The art, science and technology of pharmaceutical compounding, 2nd ed. American Pharmaceutical Association (APhA): Washington, DC, 2002; 133–159.
   Google Scholar
• Pramar, Y.; Gupta, V.D.; Zerai, T. Quantitation of spironolactone in the presence of canrenone using high-performance liquid chromatography. Drug Dev. Ind. Pharm. 1991, 17, 747–761.
   Web of Science ®Google Scholar
• Da-Ming, H.; Tian-Zhen, Z.; Feng- Jie, C.; Wen-Jing, S.; Li-Ming, Z.; Meng –Yi, Y.; Ya-Juan, W. Simultaneous identification and quantification of Canrenone and 11-α-hydroxy-canrenone by LC -MS and H PLC-UVD. J. Biomed. Biotechnol. 2011, 7, DOI:10.1155/2011/917232
   Web of Science ®Google Scholar
• Ramsay, L.E.; Shelton, J.R.; Wilkinson, D.; Tidd, M.J. Canrenone—The principal active metabolite of spironolactone. J. Clin. Pharmac. 1976, 3, 607–612.
   Web of Science ®Google Scholar
• Carballa, M.; Omil, F.; Lema, J.M. Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res. 2005, 39(19), 4790–4796.
   PubMed Web of Science ®Google Scholar
• Karaman, R.; Khamis, M.; Qurie, M.; Makharzeh, I.; Halabieh, R.; Nasser, A.; Manassra, A.; Abbadi, J.; Qtait, Q.; Bufo, S.A.; Nir, S. Removal of diclofenac potassium from wastewater using clay-micelle complex. Environ. Technol. 2011, 33(11), 1–9.
   Google Scholar
• Khamis, M.; Karaman, R.; Qurie, M.; Abbadi, J.; Nusseibeh, S.; Manassra, A.; Nir, N. Performance of micelle-clay filters for removing pollutants and bacteria from tertiary treated wastewater. J. Environ. Sci. Eng. A 2012, 1, 160–168.
   Google Scholar
• Khalaf, S.; Al-Rimawi, F.; Khamis, M.; Zimmerman, D.; Shuali, U.; Nir, S.; Scrano, L.; Bufo, S.A.; Karaman, R. Efficiency of advanced wastewater treatment plant system and laboratory-scale micelle-clay filtration for the removal of ibuprofen residues. J. Environ. Sci. Health Pt. B 2013, 48, 814–821.
   PubMed Web of Science ®Google Scholar
• Polubesova, T.; Nir, S.; Zadaka, D.; Rabinovitz, O.; Serban C.; Groisman, L. Water purification of organic pollutants by optimized micelle-clay systems. Environ. Sci. Technol. 2005, 39, 2369–2384.
   PubMed Web of Science ®Google Scholar
• Polubesova, T.; Zadaka, D.; Groisman, L.; Nir, S. Water remediation by micelle-clay system: Case study for tetracycline and sulfonamide antibiotics. Water Res. 2006, 40, 2369–2374.
   PubMed Web of Science ®Google Scholar
• Nir, S.; Zadaka-Amir, D.; Kartaginer, A.; Gonen, Y. Simulation of adsorption and flow of pollutants in a column filter: Application to micelle–montmorillonite mixtures with sand. Appl. Clay Sci. 2012, 67, 134–140.
   Google Scholar
• Mishael, Y.G.; Undabeytia, T.; Rytwo, G.; Papahadjopoulos-Sternberg, B.; Rubin, B.; Nir, S. Sulfometuron adsorption via alkylammoniumcations adsorption as monomers and micelles on montmorillonite. J. Agri. Food Chem. 2002, 50, 2856–2863.
   PubMed Web of Science ®Google Scholar
• American Public Health Association (APHA). Standard Methods for the Examination of Water and Wastewater, 19th ed. APHA, Washington, DC, 1995.
   Google Scholar
• American Public Health Association (APHA). Standard Methods for the Examination of Water and Wastewater, 21th ed. APHA, Washington, DC, 2005.
   Google Scholar
• Khalaf, S.; Al-Rimawi, F.; Khamis, M.; Nir, S.; Scrano, L.; Bufo, S.A.; Mecca, G.; Karaman, R. Efficiency of membrane technology, activated charcoal, and a micelle-clay complex for removal of the acidic pharmaceutical mefenamic acid. J. Environ. Sci. Health Pt. A 2013, 48(13), 1655–1662.
   PubMed Web of Science ®Google Scholar
• Qurie, M.; Khamis, M.; Malek, F; Nir, S.; Bufo, S.A.; Karaman, R. Stability and removal of naproxen and its metabolite by advanced membrane wastewater treatment plant and micelle-clay complex. Clean - Soil, Air, Water. 2013, 42(5), 594–600.
   Web of Science ®Google Scholar
• Sulaiman, S.; Khamis, M.; Nir, S.; Lelario, F.; Scrano, L.; Bufo, S.A.; Karaman, R. Stability and removal of dexamethasone sodium phosphate from wastewater using modified-clays. Environ. Technol. (United Kingdom) 2014, 35(15), 1945–1955.
   Google Scholar
• Sulaiman, S.; Khamis, M.; Nir, S.; Scrano, L.; Bufo, S.A.; Karaman, R. Diazepam stability in wastewater and removal by advanced membranes technology, activated carbon and micelle- clay complex. Desalin. Water Treat. 2014, DOI:10.1080/19443994.2014.981225
   Google Scholar
• Bendz, D.; Paxéus, N.A.; Ginn, T.R.; Loge, F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study. J. Hazard. Mater. 2005, 122, 195–204.
   PubMed Web of Science ®Google Scholar
• Jones, O.A.H.; Voulvoulis, N.; Lester, J.N. Human pharmaceuticals in wastewater treatment processes. Crit. Rev. Env. Sci. Technol. 2005, 35, 401–427.
   Web of Science ®Google Scholar
• Abbadi, J.; Saleh, R.; Nusseibeh, S.; Qurie, M.; Khamis, M.; Karaman, R.; Scrano, L.; Bufo, S.A. Microbial removal from secondary treated wastewater using a hybrid system of ultrafiltration and reverse osmosis. J. Environ. Sci. Engin. A1 2012, 1(7), 853–869.
   Google Scholar
• Dakiky, M.; Khamis, M.; Manasra, A.; Mereb, M. Selective adsorption of chromium (VI) in industrial waste water using low cost abundantly available adsorbents. Adv. Environ. Res. 2002, 6, 533–540.
   Google Scholar